Jump to the top of the page

Showing 770 – 780 of 1307 results

  • Critical Process Systems Group and Exyte Transaction

    William Blair acted as the exclusive financial advisor to Critical Process Systems Group (CPS Group), a portfolio company of Wynnchurch Capital, in connection with its sale to Exyte.

  • TPG and EIS Transaction

    William Blair acted as financial advisor to TPG Capital in connection with its pending growth investment in EIS.

  • Vestar Capital Partners and PetHonesty Transaction

    William Blair acted as exclusive financial advisor to Vestar Capital Partners in connection with the majority investment in PetHonesty, a leader in premium pet supplements.

  • Bridging the Gap Between the Stock Market and Real Economy

    While there will be numerous consequences, lessons, and repercussions from the current COVID-19 crisis that are likely to feature for many decades—if not centuries—to come, one of the more immediate and more obvious consequences has been that it has acted as the accelerator of many existing trends.

  • Consilio and Lawyers On Demand Transaction

    William Blair acted as the exclusive financial advisor to Consilio, a portfolio company of Stone Point Capital and Aquiline Capital Partners, in connection with its pending acquisition of Lawyers On Demand (LOD) Group, a portfolio company of Bowmark Capital LLP.

  • Japan Stewardship Code

    William Blair is a signatory to the Japan Stewardship Code.

  • Haymaker Acquisition Corp III and Biote transaction

    William Blair served as financial advisor and capital markets advisor to Haymaker Acquisition Corp. III (NASDAQ: HYAC), a publicly traded special purpose acquisition company (SPAC) in connection with its merger with Biote.

  • Pexco Has Been Acquired by Odyssey Investment Partners

    William Blair acted as the exclusive financial advisor to Pexco, a portfolio company of AEA Investors, in connection with its sale to Odyssey Investment Partners.

  • Rock Solid and Granicus Transaction

    William Blair acted as the exclusive financial advisor to Rock Solid Technologies, Inc., a portfolio company of Strattam Capital Management, LLC., in connection with its sale to Granicus, Inc., a portfolio company of Vista Equity Partners and Harvest Partners.

  • Symmetry Surgical and Aspen Surgical Transaction

    William Blair acted as lead financial advisor to Symmetry Surgical, a portfolio company of RoundTable Healthcare Partners, in connection with its sale to Aspen Surgical Products, a portfolio company of Audax Group.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures